German GPs (general practitioners) decry gene patent
This article was originally published in Clinica
EU guidelines that allow the patenting of human body parts including genes must not be transposed into German law, says the federal doctors' chamber (BAK). Last month, the BAK said it was intending to oppose any such moves ahead of a Bundestag (Lower House) debate in the coming weeks.
You may also be interested in...
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.
The FDA has almost 30 decision dates coming up before New Year’s Eve, including nearly a dozen novel agents.